# K081130: Bridgepoint Medical Crossboss Percutaneous Coronary Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Bridgepoint Medical
- Decided: May 14, 2009 after 388 days
- Product code: DQY (Catheter, Percutaneous)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K001992 (2000). 9 ancestors in all.
14 later devices descend from it; 3 cite it directly.
0 of 24 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K011562: Lumend Percutaneous Catheter, Lumend, Inc. (2002)
- K051772: Asahi Tornus Support Catheter, Asahi Intecc Co., Ltd. (2005) Summary page 1.
- K911547: Magnum-Meier Recanalization Guidewire, Schneider Intl., Ltd. (1991) Summary page 1.

## Most influential descendants
- K091841: Bridgepoint Medical Crossboss Catheter, Model M-2000 (2009), 13 descendants of its own
- K102725: Crossboss Catheter Model M-2000, Stingray Orienting Balloon Catheter Model M-1000, Stingray Guidewire Model M-3004 and M (2011), 11 descendants of its own
- K113589: Bigboss Catheter (2012), 6 descendants of its own
- K120533: Bigboss Catheters Mantatay Catheter Mantaray Guidewires (2012), 5 descendants of its own
- K193596: Wingman 14, Wingman 14C, Wingman 18, Wingman 35 (2020), 1 descendant of its own

## Indications for use
The BridgePoint Medical CrossBossTM Catheter is intended to be used in conjunction with a guidewire in order to access discrete regions of the coronary or peripheral vasculature. It may be used to facilitate placement of guidewires and other interventional devices

Source page: https://510kreport.com/device/K081130
Methodology: https://510kreport.com/methodology